Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082513 | SCV000114555 | benign | not specified | 2013-11-19 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000713562 | SCV000844186 | benign | not provided | 2017-04-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000715263 | SCV000846091 | benign | History of neurodevelopmental disorder | 2016-04-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001510460 | SCV001717496 | benign | Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000713562 | SCV001829792 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001510460 | SCV002062301 | benign | Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001815181 | SCV002062302 | benign | Intellectual disability, X-linked 50 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000713562 | SCV005277712 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000082513 | SCV000152830 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |